CX3CL1 and depressive symptom measurement: Evidence supports a strong association between depression, anxiety, cachexia and high levels of expression of cytokines IL-1β, IL-6, IL-10, TNF-α, INF-γ and fractalkine (CX3X) in cancer patients(26,27).